Sarobe, P., Pendleton, C. D., Akatsuka, T., Lau, D., Engelhard, V. H., Feinstone, S. M., & Berzofsky, J. A. (1998). Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
Styl ChicagoSarobe, P., C D. Pendleton, T. Akatsuka, D. Lau, V H. Engelhard, S M. Feinstone, a J A. Berzofsky. Enhanced in Vitro Potency and in Vivo Immunogenicity of a CTL Epitope From Hepatitis C Virus Core Protein Following Amino Acid Replacement At Secondary HLA-A2.1 Binding Positions. 1998.
Citace podle MLASarobe, P., et al. Enhanced in Vitro Potency and in Vivo Immunogenicity of a CTL Epitope From Hepatitis C Virus Core Protein Following Amino Acid Replacement At Secondary HLA-A2.1 Binding Positions. 1998.